Get the app!
Back to Trades

Smith Nancy Freda

DirectorCIK 0002019811

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 2 filings between 2026, Smith Nancy Freda, Director, has disclosed $25.0K in transactions — all concentrated in Tempest Therapeutics, Inc. (TPST). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Oct 2TPST
Tempest Therapeutics, Inc.
Smith Nancy FredaDirectorOther$0
Oct 2TPST
Tempest Therapeutics, Inc.
Smith Nancy FredaDirectorAward$25.0K

2 filings